World Journal of Urology

, Volume 32, Issue 1, pp 105–108 | Cite as

Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking

  • Matthias D. Hofer
  • Joshua J. Meeks
  • Nitin Mehdiratta
  • Michael A. Granieri
  • John Cashy
  • Chris M. Gonzalez
Original Article



To elucidate disease associations and possible etiology of lichen sclerosus (LS), we identified comorbidities present in men with LS. LS is a chronic inflammatory disease of unknown etiology affecting genitals and urethra of men commonly resulting in strictures.


Men with LS of the urethra, penis, prepuce and scrotum were identified. A control population was generated from men seen in the Department of Urology matched by age and race in a 5:1 ratio. A case–control study was performed and comorbidities identified by ICD9, CPT codes and medication use via systematic electronic medical record review. Subgroup analysis of men with urethral strictures was performed based on their LS status.


Men with LS had a significantly higher mean body mass index [31.0 (range 18.9–52.6)] compared to controls [28.1 (16.8–64.1), p = 0.001], significantly increased rate of coronary artery disease (CAD) (15.3 vs. 8.9 %, p = 0.05) as well as a twofold higher rate of diabetes mellitus (15.5 vs. 8.3 %, p = 0.02). Of men with LS and stricture disease, 11/19 (58 %) were current or former smokers, compared to 28 % of men with strictures without LS (p = 0.006). No association of LS with other morbidities like hyperlipidemia, hypertension, cerebrovascular disease, peripheral vascular disease or dermatologic disorders was found.


Men suffering from LS have an increased BMI and a higher prevalence of concomitant CAD, diabetes mellitus and tobacco use. Development and chronicity of LS may not be a purely dermatologic condition, but be associated or confounded by systemic or vascular compromise from disorders of CAD, DM and smoking.


Lichen sclerosus Diabetes mellitus Body mass index Coronary artery disease 


Conflict of interest



  1. 1.
    Pugliese JM, Morey AF, Peterson AC (2007) Lichen sclerosus: review of the literature and current recommendations for management. J Urol 178:2268–2276PubMedCrossRefGoogle Scholar
  2. 2.
    Goldstein AT, Creasey A, Pfau R, Phillips D, Burrows LJ (2011) A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol 64:99–104CrossRefGoogle Scholar
  3. 3.
    Ditkowsky SP, Falk AB, Baker N, Schaffner M (1956) Lichen sclerosis et atrophicus in childhood. AMA J Dis Child 91:52–54PubMedGoogle Scholar
  4. 4.
    Wright JE (1994) The treatment of childhood phimosis with topical steroid. Aust N Z J Surg 64:327–328PubMedCrossRefGoogle Scholar
  5. 5.
    Venn SN, Mundy AR (1998) Urethroplasty for balanitis xerotica obliterans. Br J Urol 81:735–737PubMedCrossRefGoogle Scholar
  6. 6.
    Nelson DM, Peterson AC (2011) Lichen sclerosus: epidemiological distribution in an equal access health care system. J Urol 185:522–525PubMedCrossRefGoogle Scholar
  7. 7.
    Farrell AM, Millard PR, Schomberg KH, Wojnarowska F (1999) An infective aetiology for vulval lichen sclerosus re-addressed. Clin Exp Dermatol 24:479–483PubMedCrossRefGoogle Scholar
  8. 8.
    Nasca MR, Innocenzi D, Micali G (2006) Association of penile lichen sclerosus and oncogenic human papillomavirus infection. Int J Dermatol 45:681–683PubMedCrossRefGoogle Scholar
  9. 9.
    Azurdia RM, Luzzi GA, Byren I, Welsh K, Wojnarowska F, Marren P, Edwards A (1999) Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol 140:79–83PubMedCrossRefGoogle Scholar
  10. 10.
    Howard A, Dean D, Cooper S, Kirtshig G, Wojnarowska F (2004) Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Australas J Dermatol 45:12–15PubMedCrossRefGoogle Scholar
  11. 11.
    Edmonds E, Barton G, Buisson S, Francis N, Gotch F, Game L, Haddad M, Dinneen M, Bunker C (2011) Gene expression profiling in male genital lichen sclerosus. Int J Exp Pathol 92:320–325PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Oyama N, Chan I, Neill SM, Hamada T, South AP, Wessagowit V, Wojnarowska F, D’Cruz D, Hughes GJ, Black MM, McGrath JA (2003) Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 362:118–123PubMedCrossRefGoogle Scholar
  13. 13.
    Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F (2010) The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol 24:1031–1034PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Matthias D. Hofer
    • 1
  • Joshua J. Meeks
    • 1
  • Nitin Mehdiratta
    • 1
  • Michael A. Granieri
    • 1
  • John Cashy
    • 1
  • Chris M. Gonzalez
    • 1
  1. 1.Department of Urology, Feinberg School of MedicineNorthwestern UniversityChicagoUSA

Personalised recommendations